Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Medicine, Hematology, Oncology +17

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Kyle Ra, Gertz Ma · PubMed · 1995 · 1.3K citations

Medicine, Neurology, Pathology +9

Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine

A.R. Bradwell, Hugh D Carr-Smith, Graham P. Mead et al. · Clinical Chemistry · 2001 · 645 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

Martha Skinner, Vaishali Sanchorawala, David C. Seldin et al. · Annals of Internal Medicine · 2004 · 615 citations

Medicine, Oncology, Pharmacology +14

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

Helen J. Lachmann, R Gallimore, Julian D. Gillmore et al. · British Journal of Haematology · 2003 · 433 citations · Full text

Medicine, Oncology, Pathology +12